Vaccine compositions

Disclosed is a composition comprising a Keyhole Limpet Hemocyanin (KLH)-peptide conjugate, a buffer, a saccharide, and a surfactant, wherein the peptide conjugated to KLH in the KLH-peptide conjugate comprises at least the Epidermal Growth Factor Receptor (EGFR) vIII amino acid sequence Lys-Lys-Gly-...

Full description

Saved in:
Bibliographic Details
Main Authors BUCKLEY III JOHN JOSEPH, OSBORNE BRANDI RAE, THORN JENNIFER MARIE, LEWIS LAVINIA MARINA, ZAMAN FERHANA, SINHA SANDIPAN, AHMED SYED SALEEM
Format Patent
LanguageEnglish
Published 26.02.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is a composition comprising a Keyhole Limpet Hemocyanin (KLH)-peptide conjugate, a buffer, a saccharide, and a surfactant, wherein the peptide conjugated to KLH in the KLH-peptide conjugate comprises at least the Epidermal Growth Factor Receptor (EGFR) vIII amino acid sequence Lys-Lys-Gly-Asn-Tyr, wherein the saccharide is a disaccharide.
Bibliography:Application Number: NZ20100629256